Page 27 - Berkeley Lights News Today

Share: A well seasoned SPAC management team announced a SPAC deal Tuesday to bring a cell programming company public. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with Soaring Eagle Acquisition Corp (NASDAQ: SRNG) that values the company at a pre money equity value of $15 billion. Soaring Eagle Acquisition Corp is a SPAC from Harry Sloan and Jeff Sagansky, a seasoned SPAC team that previously brought DraftKings Inc (NASDAQ: DKNG) and Skillz (NYSE: SKLZ) public. The SPAC merg...

Companies Reporting After The Bell • VIZIO Holding (NYSE:VZIO) is estimated to report quarterly loss at $0.10 per share on revenue of $484.07 million. • Talis Biomedical (NASDAQ:TLIS) is likely to report quarterly loss at $10.80 per share on revenue of $230.00 thousand. • FAT Brands (NASDAQ:FAT) is estimated to report quarterly loss at $0.06 per share on revenue of $6.75 million. • Xenon Pharmaceuticals (NASDAQ:XENE) is likely to report quarterly loss at $0.40 per share on revenue of $5...

Alger Small Cap on Berkeley Lights (BLI): “We Believe the Base Business Remains Strong” Alger, an investment management firm, published its “Alger Small Cap Focus Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.  During the quarter, the largest portfolio sector weightings were Health Care and Information Technology. The largest sector overweight was Health Care. Class A shares of the Alger Small Cap Focus Fund underperformed the Russell 2000 Growth I...

Berkeley Lights Announces Opto™ Assure For Early Manufacturability Assessment of Antibody Therapeutics EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the launch of Opto Assure, a series of assays that provides yield and product quality data at an earlier stage in cell line development. The first of the series enables direct detection of product aggregates, ensuring a faster ramp toward volume pro...

Key Companies Profiled $3,188.9 Million Healthcare experts have found the single-cell multi-omics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025. The market is driven by the need for the development of an advanced solution based on single-cell technology for clinical research in various applications such as cancer, rare disease, cell biology, and synthetic biology, among others. The market is favored by...

25 febbraio 2021 16:47 Fonte: Adnkronos #salute-e-benessere BOSTON, Feb. 25, 2021 /PRNewswire/ -- Biocytogen, a company dedicated to accelerating therapeutic antibody discovery, has announced the acquisition of a third Beacon Optofluidic system. The new instrument, developed by Berkeley Lights, will support the expansion of Biocytogens antibody discovery service platform in the greater Boston area for collaborations across the globe. Founded on its successful gene editing platform, Biocytogen ...

Share this article Share this article FREMONT, Calif., Feb. 23, 2021 /PRNewswire/ -- The premium market intelligence report published by BIS Research on the title Global Single-Cell Multi-Omics Market highlights that the market is projected to reach $3.18 billion by 2025. The study also highlights that the market is set to witness a CAGR of 21.16% during the period between 2020 and 2025. The growth is aided by factors including increasing utilization of single-cell RNA sequencing for various ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Berkeley Lights Announces CFO Transition and C-Level Additions Berkeley Lights, IncFebruary 4, 2021 GMT Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO, join Berkeley Lights Company to Report Fourth Quarter and Year-End 2020 Financial Results on February 25, 2021 EMERYVILLE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader i...

(2) EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industrys premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week. This workflow enables our customers to: Sample 4x more of the relevant biodiversity, screening up to 100,000 cells Functionally test with highly sensitive cell-based ass...

Dreamstime The highflying IPO market got off to a strong start Friday with shares of two biotechnology companies—Cullinan Management and Gracell Biotechnologies—making rousing debuts. Cullinan rose 42.43% in its first day of trading, while Gracell gained nearly 32%. The offerings continue the trend of ramped-up demand for biotechs. The sector in 2020 emerged as one of the busiest and best-performing of the market for initial public offerings. Of the roughly 100 health-care IPO...